Novo CEO pressed by Senate to cut rates of obesity, diabetes medicines CEO Lars Fruergaard Jørgensen advised lawmakers the company would take into account new talks with insurers in regards to the checklist selling prices of Wegovy and copyright should they pledge to help keep the medicines on their own https://busch-light-peach-nutriti05049.jaiblogs.com/57642332/the-healthcare-news-diaries